Leadoptik today announced the successful first-in-human clinical use of its FDA-cleared Last Inch Assessment (LIA) system.
Inspira entered into a non-binding term sheet, outlining the principal terms of a proposed two-part transaction that would include the acquisition of an advanced liquid biopsy diagnostics business, ...
RA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, ...
This results in liquid biopsy to be potentially less expensive as compared to surgical biopsies. Currently, there are several liquid biopsies in development for oncology. These technological ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...
LAFAYETTE, La. (KLFY) — Our Lady of Lourdes is now offering patients the latest in lung cancer treatment using AI. The new artificial intelligence-based software and robot-assisted biopsy technology ...
Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...
Novel research in The Journal of Molecular Diagnostics details the new method, Bridge Capture, which advances cancer diagnostics and monitoring via liquid biopsies. The cell-free DNA isolated from ...
New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection. A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by ...
RA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results